金币
UID7771
帖子
主题
积分2675
注册时间2011-11-28
最后登录1970-1-1
听众
性别保密
|

楼主 |
发表于 2015-8-14 10:29:54
|
显示全部楼层
本帖最后由 haohaochifan 于 2015-8-14 10:31 编辑
Doitasyoulike 发表于 2015-8-14 08:19 
没有强制
是,USP是说你强制,但是你不按USP方法检验,你产品让FDA批准放行?
别总黑自己国家,搞的像脑 ...
14. Must each batch of a United States Pharmacopeia (USP)-grade API be tested using the analytical procedures specified in the USP monograph?
No; however, in the event of a dispute, the compendial method is considered conclusive (see USP reference, below). Section 201(g) of the FD&C Act includes “articles intended for use as a component” of a finished drug product, including APIs (or drug substances), under its definition of a drug, and section 501(b) requires a drug recognized in USP to meet the standards of strength, quality, and purity in the official monograph or to be clearly labeled to designate how it differs from USP standards. Although each batch of a compendial article must conform to the monograph specifications/acceptance criteria, the analytical procedures used to show conformance may differ from official USP methods if the alternative methods are fully validated, suitable for use, and give equivalent or better results than the official USP method. |
|